Cytosol cathepsin-D content and proliferative activity of human breast cancer. The Comitato Italiano per il Controllo di Qualita del Laboratorio in Oncologia.
Mitogenic properties have been demonstrated in vitro for the lysosomal acidic protease cathepsin-D (cath-D). We investigated possible relationships between cath-D cytosol cell content and tumor proliferative activity in a series of 129 operable breast cancer patients. For total cytosol cath-D evaluation, a solid phase two-site immunoradiometric assay was utilized on tumor cell cytosol obtained for hormone receptor assay (DCC method). The percentage of S-phase cells was analyzed by 3H-thymidine autoradiographic assay. Median 3H-thymidine Labeling Index (3H-Tdr-LI) of the series was 2.7%; median cath-D content resulted 57 pmol/mg of protein cytosol and was significantly higher in node-positive with respect to the node-negative subgroup (p < 0.03). When classified in low, intermediate or high tumor cath-D content and slow or fast proliferative activity (cut-off: median values of the series), no significant agreement was found between the two variables. Statistical analysis, however, showed that a significant inverse correlation existed in node positive tumors between cath-D and 3H-Tdr-LI values which was even more evident in N-positive high estrogen receptor-positive (ER+) cases (coefficient of correlation = 0.6828; p = 0.0001). Cytosol cath-D content cannot be generally proposed as a direct marker of proliferative activity for operable breast cancer.
Paradiso
A
A
Experimental and Clinical Oncology Laboratory, Oncology Institute, Bari, Italy.
Mangia
A
A
Correale
M
M
Abbate
I
I
Ferri
G
G
Piffanelli
A
A
Catozzi
L
L
Amadori
D
D
Riccobon
A
A
De Lena
M
M
D001943:Breast Neoplasms / Q000737:chemistry* / Q000473:pathology*; D002402:Cathepsin D / Q000032:analysis*; D002455:Cell Division; D003600:Cytosol / Q000737:chemistry; D005260:Female; D006801:Humans; D015592:Immunoradiometric Assay; D008593:Menopause; D008875:Middle Aged
D002402:Cathepsin D